UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________

FORM 8-K

______________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~September~~December 621, 2022

______________

HEALTHTECH SOLUTIONS, INC./UT

(Exact name of registrant as specified in its charter)

______________

Utah	0-51012	84-2528660
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

181 Dante Avenue, Tuckahoe, New York 10707

(Address of Principal Executive Office) (Zip Code)

844-926-3399

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 31.0201 ~~UNREGISTERED~~ENTRY ~~SALE~~INTO OFA ~~EQUITY~~MATERIAL ~~SECURITIES~~DEFINITIVE AGREEMENT

On ~~September~~December 621, 2022 ~~the~~Healthtech ~~Registrant’s~~Solutions, Inc. (“HLTT”) ~~Board~~and ofits ~~Directors~~subsidiaries, ~~approved~~Healthtech Wound Care, Inc. (“HWC”), The Clia Lab, LLC (“TCL”), Cellsure L3C and Healthtech Management Services, Inc., entered into an Equity Exchange Agreement with World Reach Holdings, LLC (“WR Holdings”) and its affiliates, World Reach Health, LLC (“WRH”), World Reach Med, LLC (“WR Med”), Live For Today Ventures, LLC, Redi-Med Consulting, LLC, Jelena Olmstead (“Olmstead”) and James Pesoli (“Pesoli”). The Equity Exchange Agreement provides that, at a ~~grant~~Closing ofto ~~options~~occur on or prior to ~~purchase~~January 27, up2022, HLTT will issue to 15the members of WR Holdings 23,~~000~~715,~~000~~673 shares of ~~the~~HLTT ~~Registrant’s~~common stock and warrants to purchase 1,700,000 shares of HLTT common stock for $.25 ~~The~~per ~~options~~share, and will issue to WR Med, an affiliate of WR Holdings, warrants to purchase 530,769 shares of ~~were~~HLTT ~~issued~~common instock ~~compensation~~for $.25 per share. In exchange for that HLTT equity, the ~~non-interest-bearing~~members ~~loans~~of ~~made~~WR byHoldings ~~several~~will assign to HLTT fifty-one percent (51%) of the ~~Registrant’s~~membership ~~shareholders~~interest toin ~~the~~WR ~~Registrant~~Holdings and will enter into an amended operating agreement for WR Holdings with HLTT. WR Holdings ~~during~~is ~~the~~a ~~past~~holding ~~twelve~~company ~~months,~~that ~~which~~owns ~~exceeded~~all ~~$1,500,000~~of ~~and~~the ~~which~~membership ~~remain~~interest ~~outstanding~~in WRH. ByWRH ~~agreement~~is ~~among~~engaged in the ~~lenders~~business of distributing healthcare-related products and services, and has served as the ~~options~~primary ~~were~~distributor for wound care products manufactured by or on behalf of HWC since August ~~issued~~2022. toOlmstead ~~Storm~~and ~~Funding,~~Pesoli ~~LLC~~are the principal managers of WR Holdings and WRH.

The ~~options~~Equity ~~may~~Exchange beAgreement ~~exercised~~further ~~during~~provides ~~the~~that, ~~next~~on ~~three~~the ~~years~~Closing Date, tothe ~~purchase~~number ~~shares~~ of ~~the~~members ~~common~~of ~~stock for $0.25 per share, although~~ the ~~holder~~HLTT ~~may~~Board ~~not~~of atDirectors ~~any~~will ~~time~~be ~~exercise~~increased ~~the options~~ to ~~purchase~~four, aand ~~number~~that ofPesoli ~~shares~~will ~~that,~~be ~~when~~appointed ~~combined~~to ~~with~~serve ~~all~~as ~~shares~~a ~~owned~~member byof the ~~holder~~HLTT ~~and~~Board. ~~its~~In ~~affiliates~~addition, ~~would~~on ~~exceed~~that ~~4.99%~~date, ofHLTT ~~the~~will ~~Registrant’s~~enter ~~outstanding~~into ~~shares.~~Executive ~~Payment~~Employment ~~for~~Agreements with the ~~shares~~following ~~may be made in cash of by cashless exercise.~~individuals:

Executive	Position with HLTT	Position with HLTT Subsidiary
Jelena Olmstead	Chief Executive Officer	--
Manuel E. Iglesias	President	Chief Financial Officer of WR Holdings and WRH
James Pesoli	Senior Vice President	Chief Executive Officer of WRH

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

Exhibits

10-a Common Stock Purchase Warrant dated September 6, 2022 issued to Storm Funding, LLC.

10-a	Equity Exchange Agreement dated December 21, 2022 among Healthtech Solutions, Inc., Healthtech Wound Care, Inc., The Clia Lab, LLC, Cellsure L3C, Healthtech Management Services, Inc., World Reach Health, LLC, World Reach Med, LLC, World Reach Holdings, LLC, Live For Today Ventures, LLC, Redi-Med Consulting, LLC, Jelena Olmstead and James Pesoli.
104	Cover page interactive data file (embedded within the iXBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	Healthtech Solutions, Inc.
Date: September 12, 2022	By:	/s/ Manuel E. Iglesias Manuel E. Iglesias, President
Date: December 22, 2022	By:	/s/ Manuel E. Iglesias Manuel E. Iglesias, President

Filing Compare · Healthtech Solutions, Inc./UT